Holland & Knight Serves as Regulatory Counsel to Express Scripts in $54 Billion Acquisition by Cigna
BOSTON (December 21, 2018) – Holland & Knight advised Express Scripts Holding Company (NASDAQ: ESRX) on the healthcare regulatory and licensing aspects of its $54 billion sale to Cigna Corporation (NYSE: CI). The deal closed on December 20.
The combination of Cigna, a leading global health insurance company, with Express Scripts, the largest pharmacy benefit management organization in the United States, integrates two complementary healthcare service companies. Together, they are positioned to deliver better care, expanded choice and drive down healthcare costs.
Holland & Knight Partner Jeffrey Mittleman led the firm's representation of Express Scripts along with Partners Courtney Groh and Jenna Bigornia and Associates Ilenna Stein, David Weissman, Will Pezzolo, Ben Tso and Andrew Namkung.
Centerview Partners LLC and Lazard Frères & Co. LLC acted as financial advisors to Express Scripts.